EHR-to-EDC Success in a Complex Oncology, Adaptive Platform Trial

At OpenClinica, we are especially proud of the work we are doing with the I-SPY 2 Trial, sponsored and operated by Quantum Leap Healthcare Collaborative (QLHC). It’s an interventional, randomized adaptive platform trial for newly diagnosed breast cancer patients, and was one of the first and is now one of the longest-running platform trials ever. […]